Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anya Rothenbuhler

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Endocrine Connections|March 5, 2025
Early adolescence assessment of eleven boys treated with continuous subcutaneous infusion (CSGI) of recombinant LH and FSH during infancyAnne-Sophie Lambert, Trouvin Marie-Agathe, Khadidja Fouatih, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2013
Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implicationsEdra London, Anya Rothenbuhler, Maya Lodish, et al.
Patient Preference and Adherence|June 16, 2023
Young XLH Patients-Reported Experience with a Supportive Care ProgramAnya Rothenbuhler, Iva Gueorguieva, Lydia Lichtenberger-Geslin, et al.
The Journal of Pediatrics|March 13, 2010
Effects of Cushing disease on bone mineral density in a pediatric populationMaya B Lodish, Hui-Pin Hsiao, Anastasios Serbis, et al.
European Journal of Endocrinology|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatmentAudrey Vincent, Peter Kamenický, Jugurtha Berkenou, et al.
Hormone Research in Paediatrics|October 29, 2020
Demographic Characteristics, Risk Factors, and Presenting Features of Children with Symptomatic Nutritional Rickets: A French SeriesClaire Flot, Valérie Porquet-Bordes, Justine Bacchetta, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2024
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance SyndromesArianna Cremaschi, Giulia Del Sindaco, Angela Pagnano, et al.
Endocrine Connections|February 20, 2014
Therapeutic management of hypophosphatemic rickets from infancy to adulthoodAgnès Linglart, Martin Biosse-Duplan, Karine Briot, et al.
Orphanet Journal of Rare Diseases|November 12, 2022
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormoneDiana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, et al.
Endocrine Connections|January 8, 2020
Increased prevalence of overweight and obesity in children with X-linked hypophosphatemiaVolha V Zhukouskaya, Anya Rothenbuhler, Annamaria Colao, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Endocrine Connections|March 5, 2025
Early adolescence assessment of eleven boys treated with continuous subcutaneous infusion (CSGI) of recombinant LH and FSH during infancyAnne-Sophie Lambert, Trouvin Marie-Agathe, Khadidja Fouatih, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2013
Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implicationsEdra London, Anya Rothenbuhler, Maya Lodish, et al.
Patient Preference and Adherence|June 16, 2023
Young XLH Patients-Reported Experience with a Supportive Care ProgramAnya Rothenbuhler, Iva Gueorguieva, Lydia Lichtenberger-Geslin, et al.
The Journal of Pediatrics|March 13, 2010
Effects of Cushing disease on bone mineral density in a pediatric populationMaya B Lodish, Hui-Pin Hsiao, Anastasios Serbis, et al.
European Journal of Endocrinology|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatmentAudrey Vincent, Peter Kamenický, Jugurtha Berkenou, et al.
Hormone Research in Paediatrics|October 29, 2020
Demographic Characteristics, Risk Factors, and Presenting Features of Children with Symptomatic Nutritional Rickets: A French SeriesClaire Flot, Valérie Porquet-Bordes, Justine Bacchetta, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2024
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance SyndromesArianna Cremaschi, Giulia Del Sindaco, Angela Pagnano, et al.
Endocrine Connections|February 20, 2014
Therapeutic management of hypophosphatemic rickets from infancy to adulthoodAgnès Linglart, Martin Biosse-Duplan, Karine Briot, et al.
Orphanet Journal of Rare Diseases|November 12, 2022
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormoneDiana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, et al.
Endocrine Connections|January 8, 2020
Increased prevalence of overweight and obesity in children with X-linked hypophosphatemiaVolha V Zhukouskaya, Anya Rothenbuhler, Annamaria Colao, et al.
Pageof 8